Oral ganciclovir shows benefit for prevention of CMV disease in liver transplant recipients.
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000284:Administration, Oral; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D015774:Ganciclovir / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D016031:Liver Transplantation
D000998:Antiviral Agents; D015774:Ganciclovir